Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine vs dexmedetomidine effects on TcMEPs in scoliosis surgery
ChiCTR2600129663Phase 4Not yet recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine and dexmedetomidine in scoliosis (3 arms), sponsored by Sun Yat-sen University. Primary endpoints: Change in TcMEP amplitude of left tibialis anterior muscle, Total intraoperative propofol dose and 2 more. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
esketaminedexmedetomidine
03
Conditions
scoliosis
Beyond the preview
Go deeper on ChiCTR2600129663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600129663.